Skip Navigation



ToxSci Advance Access published online on November 9, 2005
Toxicological Sciences, doi:10.1093/toxsci/kfj039
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow All Versions of this Article:
89/2/399    most recent
kfj039v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Van Vleet, T. R.
Right arrow Articles by Coulombe, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Van Vleet, T. R.
Right arrow Articles by Coulombe, R. A., Jr.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Received August 19, 2005
Accepted October 19, 2005

Carcinogenicity

Aflatoxin B1 Alters the Expression of p53 in Cytochrome P450-expressing Human Lung Cells

Terry R. Van Vleet 1, Todd L. Watterson 2, Patrick J. Klein 3, and Roger A. Coulombe Jr.2*

1 Present address: Department of Toxicology, Bristol-Myers Squibb Company, Mt. Vernon, IN 47721
2 Graduate Program in Toxicology, and Department of Veterinary Sciences, Utah State University, Logan, UT 84322-4620
3 Present address: Department of Surgery, Indiana University School of Medicine, Indianapolis, IN 46202

* To whom correspondence should be addressed.
Roger A. Coulombe Jr., E-mail: rogerc{at}cc.usu.edu


  Abstract

Aflatoxin B1 is a potent dietary hepatocarcinogen in animals and probably in humans. Mutations (and altered expression) of the tumor suppresser gene p53 have been observed in liver tumors from patients exposed to high dietary AFB1. Inhalation of AFB1-laden grain dusts has been associated with an increased incidence of lung cancer in humans as well. We examined the effects of low concentrations of AFB1 on the expression of p53 and MDM2 in human bronchial epithelial cells (BEAS-2B) transfected with cDNA for either cytochrome P450 (CYP) 1A2 (B-CMV1A2) or CYP 3A4 (B3A4), two isozymes that are responsible for AFB1 activation in human liver and possibly the lung. Untreated B-CMV1A2, and B3A4 cells constitutively expressed p53. Exposure to a range (0.015-15 µM for 30 min) of AFB1 concentrations caused a concentration-dependent decline in p53 expression in B-CMV1A2 cells, and to a lesser extent, in B3A4 cells. The AFB1-mediated decrease in p53 continued for at least 12 h after 30 min exposures to 1.5 µM AFB1. Mirroring the decrease in p53 expression was a concentration-dependent increase in the expression of the 76 kDa MDM2 isoform in B-CMV1A2 and B-3A4 cells. Interestingly, AFB1 did not induce DNA laddering; an indicator of apoptotic cell death, but proteolytic activation of caspase-3 was detected in AFB1-treated B-CVM1A2 cells. In total, these data show that low, environmentally-relevant concentrations of AFB1 alter the expression of p53 and MDM2 in these human lung cells, and that cells that stably express CYP 1A2 were more susceptible to this effect than non-transfected, or 3A4-expressing cells.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.